Future Financial Wealth Management’s Novo Nordisk NVO Stock Holding History

Future Financial Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,000	Closed	-$166K	–	322
2025 Q3	$166K	Buy	3,000 +2,000	+200%	+$117K	0.1%	133
2025 Q2	$69K	Hold	1,000	–	–	0.05%	208
2025 Q1	$69.4K	Hold	1,000	–	–	0.05%	198
2024 Q4	$86K	Hold	1,000	–	–	0.06%	171
2024 Q3	$119K	Buy	+1,000	New	+$133K	0.09%	156
2024 Q2	–	Sell	-1,000	Closed	-$128K	–	336
2024 Q1	$128K	Buy	+1,000	New	+$119K	0.1%	146
2022 Q2	–	Sell	-1,000	Closed	-$56K	–	355
2022 Q1	$56K	Hold	1,000	–	–	0.05%	252
2021 Q4	$54K	Buy	+1,000	New	+$54.2K	0.04%	266

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Future Financial Wealth Management's NVO Position: Q4 2025 in Review

Future Financial Wealth Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 3,000 shares — an estimated $166K sold.

Future Financial Wealth Management first reported a position in NVO in Q4 2021 and held it in 8 quarters. The position peaked at $166K in Q3 2025. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

Future Financial Wealth Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
Future Financial Wealth Management sold 3,000 Novo Nordisk shares in Q4 2025, an estimated $166K.
Future Financial Wealth Management first reported a position in Novo Nordisk in Q4 2021 and held it in 8 quarters.
Future Financial Wealth Management's Novo Nordisk position peaked at $166K in Q3 2025.
1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Future Financial Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.